GENEXPLAIN GMBH - Germany 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 10
As coordinator: 0
As participant: 10
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 2.687.400 260.539 1
2019 0 4.497.935 148.875 1
2018 0 5.996.360 284.469 1
2017 0 8.614.030 635.316 2
2015 0 445.500 18.000 1
2013 0 10.548.374 584.599 1
2012 0 17.993.306 1.399.554 2
2011 0 11.999.996 496.720 1

Networking:

Partners:

Institution:Projects [No]:
ROYAL COLLEGE OF SURGEONS IN IRELAND4
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE3
MIMETAS BV3
CARTHERA2
CONSIGLIO NAZIONALE DELLE RICERCHE2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
INTERNATIONAL BRAIN TUMOUR ALLIANCE2
KATHOLIEKE UNIVERSITEIT LEUVEN2
MEDIZINISCHE HOCHSCHULE HANNOVER2
PINTAIL2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
STICHTING KATHOLIEKE UNIVERSITEIT2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITY OF HELSINKI2
VIB VZW2
AARHUS UNIVERSITETSHOSPITAL SKEJBY1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACIES SAS1
ACOUSTICVIEW1
AGILENT TECHNOLOGIES BELGIUM NV1
ARJUNA THERAPEUTICS SL1
ASOCIACION ESPANOLA DE NORMALIZACION1
AULCHENKO YURY SERGEYEVICH1
BAYER1
BIOCOMPUTING PLATFORMS LTD OY1
BMS FRANCE1
BOSTON SCIENTIFIC LIMITED1
CANCER TRIALS IRELAND CLG1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRUM FUR ANGEWANDTE NANOTECHNOLOGIE1
CHAMPIONS ONCOLOGY INC1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
DESTINA GENOMICA1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
EPIGENOMICS1
ERASMUS UNIVERSITEIT ROTTERDAM1
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS1
FUNDACIO EURECAT1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O1
GENOS DOO ZA VJESTACENJE I ANALIZU1
GOETEBORGS UNIVERSITET1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
H LUNDBECK AS1
HALIODX1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSILICO BIOTECHNOLOGY1
INSTITUT PASTEUR DE LILLE1
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL1
IRISH CLINICAL ONCOLOGY RESEARCH GROUP LIMITED LBG1
JOHNS HOPKINS UNIVERSITY1
KAROLINSKA INSTITUTE1
LABORATOIRE NATIONAL DE SANTE1
LEIDEN UNIVERSITY MEDICAL CENTER1
LIFEGLIMMER1
LUXEMBOURG INSTITUTE OF HEALTH1
MILTENYI BIOTEC BV & CO KG1
NEOS SURGERY S L1
NOVAMEN SAS1
ONCURIOUS NV1
OPTIMATA1
OPTOELETTRONICA ITALIA1
OSLO UNIVERSITETSSYKEHUS HF1
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG1
PEPSCOPE BV1
PHARMATICS LIMITED1
POLITECHNIKA LODZKA1
SB SCIENCE MANAGEMENT UG1
SORBONNE UNIVERSITE1
TECHNISCHE UNIVERSITEIT EINDHOVEN1
TERVEYDEN JA HYVINVOINNIN LAITOS1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
TEVA PHARMACEUTICALS EUROPE BV1
THE BRIGHAM AND WOMEN'S HOSPITAL INC1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE HEBREW UNIVERSITY OF JERUSALEM1
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL1
THE UNIVERSITY OF AUCKLAND1
THE UNIVERSITY OF EDINBURGH1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF WARWICK1
TWOPTICS SYSTEMS DESIGN SL1
UCB BIOPHARMA1
ULTRASION SL1
UNIVERSIDAD DE GRANADA1
UNIVERSIDADE FEDERAL DE SANTA CATARINA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITA DEGLI STUDI DI TRENTO1
UNIVERSITAET STUTTGART1
UNIVERSITAET ZUERICH1
UNIVERSITAETSKLINIKUM AACHEN1

Constancy:

Total number of partners: 132
Partner loyalty:
Frequent Partner: (> 2 projects): 10
Rare Partner: 122
Frequent / Rare Partner Ratio: 0.08

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment GLIORESOLVEparticipant2.687.40021
2019-02-01PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease PD-MitoQUANTparticipant4.497.93514
2018-01-01Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions COLOSSUSparticipant5.996.36014
2017-09-01Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics GLIOTRAINparticipant3.836.77223
2017-01-01Optogenetic Protein Therapy for Multiple Sclerosis OPTOGENERAPYparticipant4.777.25811
2015-12-01microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis miRNA-DisEASYparticipant445.5007
2013-01-01A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol RESOLVEparticipant10.548.37414
2012-12-01Systems medicine of chronic inflammatory bowel disease SYSMEDIBDparticipant11.999.99812
2012-10-01Methods for Integrated analysis of Multiple Omics datasets MIMOMICSparticipant5.993.30815
2011-01-01Systems Biology of Colorectal Cancer SYSCOLparticipant11.999.99611